Review article · 2024 · Open access

Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials

Steven Berendsen, Silke Berendse, Jeanne van der Torren, Jentien M. Vermeulen, Lieuwe de Haan

EClinicalMedicine, 67, 102392 · Published 1 January 2024 · DOI 10.1016/j.eclinm.2023.102392

Open PDFView at the publisherCite this paper

In brief

“Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials” is a 2024 review article by Steven Berendsen and 4 co-authors, published in EClinicalMedicine. OpenAlex counts 74 citations as of 20 November 2026, which puts it in the top 2% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at EClinicalMedicine.

Citations
74
Most cited in
2026 (35)
Field-weighted impact
3.73
References
29
Authors
5

Abstract

Background Cognitive behavioural therapy (CBT) forms the standard psychotherapy for schizophrenia spectrum disorders (SSD). We aimed to summarize and evaluate the evidence on the effectiveness of CBT for SSD. Methods In this umbrella review, we searched PubMed, Embase, Cochrane Database, and PsychInfo, for meta-analyses of randomised controlled trials (RCTs) of CBT in SSD published between database inception up to Aug 18, 2023. Inclusion criteria were RCTs investigating individually provided CBT in a population of patients with SSD, compared to either standard care, treatment as usually, or any other psychosocial therapies. No restrictions concerning follow-up or language were applied. We used the "assessment of multiple systematic reviews" (AMSTAR-2) appraisal checklist for the evaluation of methodological quality of meta-analysis. We extracted summary metrics from eligible studies in duplicate. The strength of evidence was classified by the sample size, p-value, excess significance bias, prediction intervals, significance of largest study, and heterogeneity. The strength of evidence was ranked according to established criteria as: convincing, highly suggestive, suggestive, weak, or not significant. Primary outcomes were general psychopathology, positive and negative symptoms. This study is registered in PROSPERO, CRD42022334671. Findings We found 26 eligible meta-analyses, of which 16 meta-analyses provided sufficient data. Using the AMSTAR-2, we found limitations in details concerning the selection of study design, quality of the search and reporting of funding in included meta-analyses. A minority of 42.9% of the comparisons showed a significant result in favor of CBT; 57.1% were non-significant with no convincing or highly suggestive evidence. Suggestive evidence was found in favor of CBT for general psychopathology (6.2%, N = 34 RCTs, effect size (ES) = −0.33 (−0.47; −0.19), I 2 = 67.93), delusions (16.7%, N = 27, ES = 0.36 (0.22; 0.51), I 2 = 50.47), and hallucinations (33.3%, N = 28, ES = 0.32 (0.19; 0.46), I 2 = 45.14) at the end of treatment (EoT). Weak (N = 34 RCTs, ES = −0.13 (−0.24; −0.02), I 2 = 51.28), or non-significant evidence (N = 28 RCTs, ES = 0.12 (−0.03; 0.27) I 2 = 64.63) was found for negative symptoms at EoT. At longer follow-up, evidence became weak or non-significant. Interpretation Findings suggest that the effectiveness of CBT on general and positive symptoms in SSD at EoT was small to medium, while we found inconsistent evidence for a sustainable effect. CBT has no convincing impact on other relevant outcomes. Guidelines may use these results to specify their recommendations. Funding None.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Berendsen, S., Berendse, S., van der Torren, J., Vermeulen, J. M., & de Haan, L. (2024). Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials. EClinicalMedicine, 67, 102392. https://doi.org/10.1016/j.eclinm.2023.102392

MLA 9

Berendsen, Steven, et al. “Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials.” EClinicalMedicine, vol. 67, 2024, p. 102392. https://doi.org/10.1016/j.eclinm.2023.102392.

Chicago

Berendsen, Steven, Silke Berendse, Jeanne van der Torren, Jentien M. Vermeulen, and Lieuwe de Haan. 2024. “Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials.” EClinicalMedicine 67: 102392. https://doi.org/10.1016/j.eclinm.2023.102392.

Harvard

Berendsen, S. et al. (2024) ‘Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials’, EClinicalMedicine, 67, p. 102392. doi:10.1016/j.eclinm.2023.102392.

IEEE

S. Berendsen, S. Berendse, J. van der Torren, J. M. Vermeulen, and L. de Haan, “Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials,” EClinicalMedicine, vol. 67, p. 102392, 2024, doi: 10.1016/j.eclinm.2023.102392.

BibTeX

@article{berendsen2024cognitive,
  title     = {{Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials}},
  author    = {Berendsen, Steven and Berendse, Silke and van der Torren, Jeanne and Vermeulen, Jentien M. and de Haan, Lieuwe},
  journal   = {EClinicalMedicine},
  year      = {2024},
  volume    = {67},
  pages     = {102392},
  doi       = {10.1016/j.eclinm.2023.102392},
  url       = {https://doi.org/10.1016/j.eclinm.2023.102392}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202477
20253232
20263535

Its field-weighted citation impact is 3.73: it has been cited 3.73 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • cognitive behavioral therapy
  • schizophrenia spectrum disorders
  • psychosis
  • delusions
  • hallucinations
  • positive and negative symptoms
  • general psychopathology
  • treatment effectiveness

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Berendsen, S., Berendse, S., van der Torren, J., Vermeulen, J. M., & de Haan, L. (2024). Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials. EClinicalMedicine, 67, 102392. https://doi.org/10.1016/j.eclinm.2023.102392

How many times has this paper been cited?

74 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at EClinicalMedicine: sign in and open the PDF from this page.

Who wrote this paper?

Steven Berendsen, Silke Berendse, Jeanne van der Torren, Jentien M. Vermeulen, Lieuwe de Haan.

What is the DOI of this paper?

10.1016/j.eclinm.2023.102392, permanently at https://doi.org/10.1016/j.eclinm.2023.102392. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.